The Treatment of Dry Eye

Akramian, 1998, Estrogen therapy in keratoconjunctivitis sicca, Adv Exp Med Biol, 438, 1005, 10.1007/978-1-4615-5359-5_145 Argueso, 1998, Analysis of human ocular mucus, Cornea, 17, 200, 10.1097/00003226-199803000-00015 Avisar, 2000, Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis, Cornea, 19, 145, 10.1097/00003226-200003000-00005 Avisar, 1988, Our further experience with bromhexine in keratoconjunctivitis sicca, Ann Ophthalmol, 20, 382 Baldone, 1983, Extended wear contact lenses, Am J Ophthalmol, 15, 595 Becquet, 1998, Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface, Curr Eye Res, 17, 19, 10.1080/02713689808951223 Becquet, 1998, Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface, Curr Eye Res, 17, 419, 10.1080/02713689808951223 Benson, 1992, Efficacy of laser punctal occlusion, Ophthalmology, 99, 618, 10.1016/S0161-6420(92)31928-1 Berdy, 1992, Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects, Arch Ophthalmol, 110, 528, 10.1001/archopht.1992.01080160106043 Blom, 1999, Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment, Arch Otolaryngol Head Neck Surg, 125, 561, 10.1001/archotol.125.5.561 Boroojerdi, 1998, Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy, J Neurol Neurosurg Psychiatry, 65, 111, 10.1136/jnnp.65.1.111 Bourcier, 2000, Expression of CD40 and CD40 ligand in the human conjunctival epithelium, Invest Ophthalmol Vis Sci, 41, 120 Brignole, 2000, Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes, Invest Ophthalmol Vis Sci, 41, 1356 Bron, 1998, Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes, Eye, 12, 839, 10.1038/eye.1998.215 Bron, 1998, Polyacrylic acid gel in patients with dry eyes, Eur J Ophthalmol, 8, 81, 10.1177/112067219800800206 Burstein, 1980, Corneal cytotoxicity of topically applied drugs, vehicles and preservatives, Surv Ophthalmol, 25, 15, 10.1016/0039-6257(80)90072-7 Carney, 1979, Human tear buffering capacity, Arch Ophthalmol, 97, 951, 10.1001/archopht.1979.01020010509028 Chen, 1970, Compositions producing adhesion through hydration, 163 De Clerk, 1992, Human herpes virus 6 in Sjögrens syndrome, 303 Dentinger, 2000, Stability of famotidine in an extemporaneously compounded oral liquid, Am J Health Syst Pharm, 57, 1340, 10.1093/ajhp/57.14.1340 Diebold, 1998, Carbomer- versus cellulose-based artificial-tear formulations, Cornea, 17, 433, 10.1097/00003226-199807000-00015 Diestelhorst, 1999, Dry Drops, Graefes Arch Clin Exp Ophthalmol, 237, 394, 10.1007/s004170050250 Dougherty, 1991, The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci, Invest Ophthalmol Vis Sci, 32, 2970 Driot, 1992, Beneficial effects of a retinoic acid analog, CBS-211 A, on an experimental model of keratoconjunctivitis sicca, Invest Ophthalmol Vis Sci, 33, 190 Esmaeli, 2000, Immunohistochemical evidence for estrogen receptors in meibomian glands, Ophthalmology, 107, 180, 10.1016/S0161-6420(99)00040-8 Farris, 1994, Contact lenses and the dry eye, Int Ophthalmol Clin, 34, 129, 10.1097/00004397-199403410-00012 Felt, 1999, Topical use of chitosan in ophthalmology, Int J Pharm, 180, 185, 10.1016/S0378-5173(99)00003-4 Ferraccioli, 1996, Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjogrens syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine, Clin Exp Rheumatol, 14, 367 Foster, 1986, Cicatricial pemphigoid, Trans Am Ophthalmol Soc, 84, 527 Foulks, 1998, The now and future therapy of the non-Sjogrens dry eye, Adv Exp Med Biol, 438, 959, 10.1007/978-1-4615-5359-5_136 Fox, 1984, Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca, Arthritis Rheum, 27, 459, 10.1002/art.1780270415 Freeman, 1975, The punctum plug, Trans Am Acad Ophthalmol Otolaryngol, 79, OP874 Frucht-Pery, 1993, Efficacy of doxycycline and tetracycline in ocular rosacea, Am J Ophthalmol, 116, 88, 10.1016/S0002-9394(14)71750-7 Gao, 1998, The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca, Cornea, 17, 654, 10.1097/00003226-199811000-00014 Geerling, 2000, Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye, Graefes Arch Clin Exp Ophthalmol, 238, 45, 10.1007/s004170050008 Geerling, 1998, Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca, Ophthalmology, 105, 327, 10.1016/S0161-6420(98)93406-6 Gilbard, 1994, Human tear film electrolyte concentrations in health and dry-eye disease, Int Ophthalmol Clin, 34, 27, 10.1097/00004397-199403410-00005 Gilbard, 1989, Open-label crossover study of vitamin A ointment as a treatment for keratoconjunctivitis sicca, Ophthalmology, 96, 244, 10.1016/S0161-6420(89)32909-5 Gilbard, 1992, An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca, Ophthalmology, 99, 600, 10.1016/S0161-6420(92)31929-3 Gilbard, 1989, Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation, Am J Ophthalmol, 107, 348, 10.1016/0002-9394(89)90657-0 Gilbard, 1990, Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels, Invest Ophthalmol Vis Sci, 31, 1381 Gilger, 1999, Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs, J Interferon Cytokine Res, 19, 901, 10.1089/107999099313433 Glatt, 1991, Acute dacryocystitis after punctal occlusion of keratoconjunctivitis sicca, Am J Ophthalmol, 111, 769, 10.1016/S0002-9394(14)76787-X Gobbels, 1991, Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry, Graefes Arch Clin Exp Ophthalmol, 229, 549, 10.1007/BF00203320 Gunduz, 1994, Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogrens syndrome, Acta Ophthalmol (Copenh), 72, 438, 10.1111/j.1755-3768.1994.tb02792.x Guzman, 1996, Quantitation of mucin RNA by PCR reveals induction of both MUC2 and MUC5AC mRNA levels by retinoids, Am J Physiol, 271, L1023 Heiligenhaus A, Koch JM, Kemper D, et al: [Therapy of dry eye disorders]. Klin Monatsbl Augenheilkd 204:162–8, 1994 Hunt, 1987, Mucoadhesive polymers in drug delivery systems Ichikawa, 1988, Clinical trial of ambroxol (Mucosolvan) in Sjogrens syndrome, Tokai J Exp Clin Med, 13, 165 Jones, 1965, The management of keratoconjunctivitis sicca, Trans Ophthalmol Soc UK, 85, 379 Jumblatt, 1998, Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva, Exp Eye Res, 67, 341, 10.1006/exer.1998.0520 Kobayashi, 1997, Effect of retinol palmitate as a treatment for dry eye, Ophthalmologica, 211, 358, 10.1159/000310829 Kunert, 1999, Effect of cyclosporine ophthalmic emulsion on the number of inflammatory cells and goblet cells in conjunctival biopsies with dry eye (abstract), Invest Ophthalmol Vis Sci, 40, S771 Laibovitz, 1993, Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca, Cornea, 12, 315, 10.1097/00003226-199307000-00007 Lamberts, 1994, Punctal occlusion, Int Ophthalmol Clin, 34, 145, 10.1097/00004397-199403410-00014 Lebowitz, 1988, Ocular effects of oral retinoids, J Am Acad Dermatol, 19, 209, 10.1016/S0190-9622(88)70166-8 Lee, 1992, The lacrimal gland synthesizes retinol-binding protein, Exp Eye Res, 55, 163, 10.1016/0014-4835(92)90104-Z Lemp, 1999, The 1998 Castroviejo Lecture. New strategies in the treatment of dry- eye states, Cornea, 18, 625, 10.1097/00003226-199911000-00001 Lemp, 1994, Management of the dry-eye patient, Int Ophthalmol Clin, 34, 101, 10.1097/00004397-199403410-00010 Lenton, 1999, Effect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusis, J Refract Surg, 15, S227 Li, 1992, Applications and properties of chitosan, J Bioact Comp Polym, 7, 370, 10.1177/088391159200700406 Linberg, 1988, Symptoms of canalicular obstruction, Ophthalmology, 95, 1077, 10.1016/S0161-6420(88)33057-5 Liu, 1999, Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency, Ophthalmology, 106, 939, 10.1016/S0161-6420(99)00513-8 Lopez Bernal, 1991, Quantitative evaluation of the corneal epithelial barrier, Curr Eye Res, 10, 645, 10.3109/02713689109013856 Macri, 2000, A standardized visual scale for evaluation of tear fluorescein clearance, Ophthalmology, 107, 1338, 10.1016/S0161-6420(00)00101-9 Marsh, 1999, Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome, Ophthalmology, 106, 811, 10.1016/S0161-6420(99)90171-9 Mathers, 2000, Objective demonstration of tear stimulation with oral pilocarpine in dry eye patients, Invest Ophthalmol Vis Sci, 41, S60 Mathers, 1998, Menopause and tear function, Cornea, 17, 353, 10.1097/00003226-199807000-00002 Mundasad, 2000, Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in healthy subjects (abstract), Invest Ophthalmol Vis Sci, 41, S928 Murphy, 1996, Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease, Bone Marrow Transplant, 18, 641 Murube, 1986, Transplantation of salivary gland to the lacrimal basin, Scand J Rheumatol, 61, 264 Murube, 1995, Surgical treatment of the dry eye, 227 Murube, 1998, Classification of artificial tears. II, Adv Exp Med Biol, 438, 705, 10.1007/978-1-4615-5359-5_100 Murube, 1996, Treatment of dry eye by blocking the lacrimal canaliculi, Surv Ophthalmol, 40, 463, 10.1016/S0039-6257(96)82013-3 Murube, 1995, Treatment of dry eye by punctum patch, Orbit, 14, 1, 10.3109/01676839509149156 Murube, 1998, Classification of artificial tears. I, Adv Exp Med Biol, 438, 693, 10.1007/978-1-4615-5359-5_99 Nelson, 1998, Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjogrens syndrome. The MGI PHARMA Sjogrens Syndrome Study Group, Adv Exp Med Biol, 438, 979, 10.1007/978-1-4615-5359-5_140 Nepp J, Derbolav A, Haslinger-Akramian J, et al: [Effect of acupuncture in keratoconjunctivitis sicca (see comments)]. Klin Monatsbl Augenheilkd 215:228–32, 1999 Oechsner, 1999, Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome, Eur J Pharm Biopharm, 47, 113, 10.1016/S0939-6411(98)00070-8 Palmer, 1996, Longitudinal tear study after cyclosporine in kidney transplant recipients, Ophthalmology, 103, 670, 10.1016/S0161-6420(96)30636-2 Papas, 1998, Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogrens syndrome, Adv Exp Med Biol, 438, 973, 10.1007/978-1-4615-5359-5_139 Park, 1987, Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels, Pharm Res, 4, 457, 10.1023/A:1016467219657 Pflugfelder, 1998, Advances in the diagnosis and management of keratoconjunctivitis sicca, Curr Opin Ophthalmol, 9, 50, 10.1097/00055735-199808000-00009 Pflugfelder, 1999, Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogrens syndrome keratoconjunctivitis sicca, Curr Eye Res, 19, 201, 10.1076/ceyr.19.3.201.5309 Pisella, 2000, Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits, Ophthalmic Res, 32, 3, 10.1159/000055579 Power, 1993, Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjogrens syndrome, Cornea, 12, 507, 10.1097/00003226-199311000-00008 Quarterman, 1997, Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline, Arch Dermatol, 133, 49, 10.1001/archderm.133.1.49 Rapoza, 1992, Pyogenic granuloma as a complication of silicone punctal plugs, Am J Ophthalmol, 113, 454, 10.1016/S0002-9394(14)76173-2 Redmond, 1992, Punctal occlusion with collagen implants, Ophthalmic Surg, 23, 642 Rieger, 1990, Lipid-containing eye drops, Ophthalmologica, 201, 206, 10.1159/000310154 Riemann, 1999, Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland, Ophthalmology, 106, 2322, 10.1016/S0161-6420(99)90534-1 Rocha, 2000, Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues, Br J Ophthalmol, 84, 76, 10.1136/bjo.84.1.76 Sahlin, 1996, Evaluation of the lacrimal drainage function by the drop test, Am J Ophthalmol, 122, 701, 10.1016/S0002-9394(14)70490-8 Sahlin, 2000, Effect of eyelid botulinum toxin injection on lacrimal drainage, Am J Ophthalmol, 129, 481, 10.1016/S0002-9394(99)00408-0 Sall, 2000, Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group, Ophthalmology, 107, 631, 10.1016/S0161-6420(99)00176-1 Selek, 2000, Evaluation of retinoic acid ophthalmic emulsion in dry eye, Eur J Ophthalmol, 10, 121, 10.1177/112067210001000205 Shimmura, 1998, Viscosity-dependent fluid dynamics of eyedrops on the ocular surface, Am J Ophthalmol, 125, 386, 10.1016/S0002-9394(99)80151-2 Ship, 1999, Treatment of primary Sjogrens syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route, J Interferon Cytokine Res, 19, 943, 10.1089/107999099313497 Singer, 1989, Vitamin A in Stevens-Johnson Syndrome, Ann Ophthalmol, 21, 209 Smart, 1984, An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery, J Pharm Pharmacol, 36, 295, 10.1111/j.2042-7158.1984.tb04377.x Smith, 1999, Immunohistochemical identification of androgen receptors in human lacrimal glands, Curr Eye Res, 18, 300, 10.1076/ceyr.18.4.300.5362 Sommer, 1998, Xerophthalmia and vitamin A status, Prog Retin Eye Res, 17, 9, 10.1016/S1350-9462(97)00001-3 Soong, 1988, Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study, Ophthalmology, 95, 1442, 10.1016/S0161-6420(88)33009-5 Spiera, 1997, Botulinum toxin increases tearing in patients with Sjogrens syndrome, J Rheumatol, 24, 1842 Stamler, 1990, A simple and reliable technique for permanent lateral tarsorrhaphy, Arch Ophthalmol, 108, 125, 10.1001/archopht.1990.01070030131044 Steinfeld, 1999, Zidovudine in primary Sjogrens syndrome, Rheumatology (Oxford), 38, 814, 10.1093/rheumatology/38.9.814 Stern, 1988, The pathology of dry eye, Cornea, 17, 584, 10.1097/00003226-199811000-00002 Stevenson, 2000, Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease, Ophthalmology, 107, 967, 10.1016/S0161-6420(00)00035-X Sugita, 2000, Detection of bacteria biofilm formation in punctal plug holes (abstract), Invest Ophthalmol Vis Sci, 41, S69 Sullivan, 1997, Androgen stimulation of lacrimal gland function in mouse models of Sjogrens syndrome, J Steroid Biochem Mol Biol, 60, 237, 10.1016/S0960-0760(96)00190-2 Sullivan, 1996, Identification and endocrine control of sex steroid binding sites in the lacrimal gland, Curr Eye Res, 15, 279, 10.3109/02713689609007622 Sullivan, 1999, Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency?, Invest Ophthalmol Vis Sci, 40, 1261 Sullivan, 1999, Androgens and dry eye in Sjogrens syndrome, Ann NY Acad Sci, 876, 312, 10.1111/j.1749-6632.1999.tb07656.x Takaya M, Ichikawa Y, Yamada C, et al: [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjogrens syndrome]. Ryumachi 37:453–7, 1997 Terada, 1994, Prevalence of serum and salivary antibodies to HTLV-1 in Sjogrens syndrome, Lancet, 344, 1116, 10.1016/S0140-6736(94)90630-0 Tiffany, 1991, Lipid-containing eye drops, Ophthalmologica, 203, 47, 10.1159/000310224 Tosti, 1988, Thimerosal, Contact Dermatitis, 18, 268, 10.1111/j.1600-0536.1988.tb02831.x Tripathi, 1989, Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro, Lens Eye Toxic Res, 6, 395 Tseng, 1985, Topical retinoid treatment for various dry-eye disorders, Ophthalmology, 92, 717, 10.1016/S0161-6420(85)33968-4 Tsubota, 1994, New approaches to dry-eye therapy, Int Ophthalmol Clin, 34, 115, 10.1097/00004397-199403410-00011 Tsubota, 1995, Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjogrens syndrome patients, Acta Ophthalmol Scand, 73, 425, 10.1111/j.1600-0420.1995.tb00302.x Tsubota, 1999, Treatment of dry eye by autologous serum application in Sjogrens syndrome, Br J Ophthalmol, 83, 390, 10.1136/bjo.83.4.390 Tsubota, 1999, Treatment of persistent corneal epithelial defect by autologous serum application, Ophthalmology, 106, 1984, 10.1016/S0161-6420(99)90412-8 Tsubota, 1999, New treatment of dry eye, Br J Ophthalmol, 83, 767, 10.1136/bjo.83.7.767 Tsubota, 1998, Use of topical cyclosporin A in a primary Sjogrens syndrome mouse model, Invest Ophthalmol Vis Sci, 39, 1551 Turner, 2000, Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion, Cornea, 19, 492, 10.1097/00003226-200007000-00018 Ubels, 1984, Vitamin A is present as retinol in the tears of humans and rabbits, Curr Eye Res, 3, 815, 10.3109/02713688409000793 Ubels, 1995, Effects of preservative-free artificial tear solutions on corneal epithelial structure and function, Arch Ophthalmol, 113, 371, 10.1001/archopht.1995.01100030127036 Vivino, 1999, Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome, Arch Intern Med, 159, 174, 10.1001/archinte.159.2.174 Wee, 1995, Effect of artificial tears on cultured keratocytes in vitro, Cornea, 14, 273, 10.1097/00003226-199505000-00008 Wenderlein, 1996, [Quality of life and estrogen therapy, Study of, 716, 226 Will, 2000, Pyogenic granuloma complicating ParasolTM (OdysseyTM) silicone punctal plug occlusion, Invest Ophthalmol Vis Sci, 41, S69 Willis, 1987, The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study, Ophthalmology, 94, 514, 10.1016/S0161-6420(87)33417-7 Xie, 1993, Effects of three kinds of topical eye-drops on the experimental rabbit dry eye, Chin Med J (Engl), 106, 196 Yamada, 1998, Fluorophotometric measurement of the buffering action of human tears in vivo, Curr Eye Res, 17, 1005, 10.1076/ceyr.17.10.1005.5239 Yen, 1999, Punctal occlusion decreases tear production, clearance, and ocular surface sensation (abstract), Invest Ophthalmol Vis Sci, 40, S980 Yerxa, 2000, Cellular localization of P2Y2 receptor gene expression in primate tissues by nonisotopic in situ hybridization (abstract), Invest Ophthalmol Vis Sci, 41, S871